Echinacea: Uses, Efficacy, and Considerations

1. Studied Conditions

Echinacea has been studied for a variety of health conditions, including:

• Colds and upper respiratory infections
• Immune system enhancement
• Inflammation-related disorders
• Urinary tract infections
• Wound healing
• Herpes simplex virus

2. Efficacy in Treating Conditions

The effectiveness of Echinacea in treating these conditions is a subject of debate. Research shows mixed results:

• Colds: Some studies suggest a possible benefit in reducing the duration and severity of colds, but evidence is not conclusive.
• Immune Support: There is some evidence that Echinacea can stimulate the immune system, but results vary.
• Other Conditions: Limited evidence exists for the efficacy of Echinacea in treating other conditions.

3. Health Benefits

Echinacea is believed to offer various health benefits:

• May boost immune function
• Potential to reduce inflammation
• Can possibly help in alleviating pain
• May have antioxidant properties
• Could aid in skin health, such as improving eczema and other skin conditions

4. Downsides

While Echinacea is generally considered safe, it can have downsides:

• Allergic reactions, particularly in those allergic to other plants in the daisy family
• Possible interactions with medications, such as immunosuppressants
• Gastrointestinal issues
• Dizziness
• Headaches

5. Genetic Variations and Echinacea

There is limited research on the relationship between genetic variations and the effects of Echinacea. However, individuals with certain genetic profiles may:

• Experience different levels of efficacy
• Have varying susceptibilities to side effects

More research is needed to understand the genetic factors that could influence Echinacea's benefits and risks.

Echinacea and Its Effects

Echinacea is a herbal remedy traditionally used to boost the immune system and has been studied for its potential cytochrome P450 enzymes and P-glycoprotein interactions at high doses. It may influence CYP3A4, CYP1A2, and CYP2C9, although more comprehensive data is needed for conclusive guidance on herb-drug interactions.

Cytosolic Ca2+ Levels and Echinacea

Studies have found that Echinacea purpurea extracts cause a rapid, transient increase in cytosolic Ca2+ levels in HEK293 cells, independent of cannabinoid type 2 (CB2) receptors. These effects involve activation of the phospholipase C and IP3 receptor signaling pathways and may involve store-operated calcium entry, indicating a distinct pathway from that used in immune cells.

Antioxidant Properties and Echinacea

Echinacea purpurea root extracts exhibit antioxidant properties, particularly cichoric acid, which has been found to be the most active in inhibiting the oxidation of human low-density lipoprotein (LDL) in vitro. These antioxidant effects, including potential synergistic effects between different plant constituents, suggest that multiple components contribute to Echinacea's health benefits.

Complementary and Alternative Medicine (CAM) Use

Herbal remedy use, including Echinacea, is prevalent among long-term breast cancer survivors and African American breast cancer survivors, with varied associations with survival rates and health-related quality of life (QOL). The use of Echinacea and other supplements among athletes is also common, although there is insufficient evidence to support their immune-boosting effects.

Efficacy in Disease Prevention and Treatment

Echinacea is frequently used for disease prevention, including respiratory infections. The studies have explored its potential to enhance immune response and reduce the severity and duration of infections, such as the common cold, with mixed results. Echinacea has also been studied for its potential as an adjuvant in vaccines.

Echinacea's Interaction with Other Medications

Research has examined Echinacea's potential to interact with other medications, particularly its effect on cytochrome P450 enzymes and the P-glycoprotein transporter system. While it may interact with drugs metabolized by CYP3A or CYP1A2, the overall risk of interaction with drugs metabolized by P450 enzymes appears to be minimal with prolonged use.

Immune Function and Performance in Athletes

Echinacea has been evaluated for its effects on immune function in athletes, with some studies suggesting improvements in erythropoietin levels, erythropoietic status, and running economy. However, there is no consistent evidence to support the use of Echinacea to prevent exercise-induced immune dysfunction.

Safety and Adverse Effects

While Echinacea is generally considered safe for short-term use, it has been associated with a range of adverse effects from mild to serious, including allergic reactions, particularly in atopic individuals. Caution is advised for those with ragweed allergies and during pregnancy and breastfeeding due to limited safety data.

References:

1. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions
2. Echinacea-induced cytosolic Ca2+ elevation in HEK293
3. Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins
4. Dietary supplements commonly used for prevention
5. The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors--results of a prospective study
6. Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women's health study
7. Identification and exploration of herb-drug combinations used by cancer patients
8. Position statement. Part two: Maintaining immune health
9. Herbal supplements and athlete immune function--what's proven, disproven, and unproven?
10. Effects of Echinaforce® treatment on ex vivo-stimulated blood cells
11. Seasonal variations in the concentrations of lipophilic compounds and phenolic acids in the roots of Echinacea purpurea and Echinacea pallida
12. Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors
13. Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MS
14. TLC and HPLC Analysis of Alkamides in Echinacea Drugs1,2
15. Macrophage activating effects of new alkamides from the roots of Echinacea species
16. Efficient counter-current chromatographic isolation and structural identification of two new cinnamic acids from Echinacea purpurea
17. Echinacea purpurea extracts modulate murine dendritic cell fate and function
18. Adjuvant activity of Chinese herbal polysaccharides in inactivated veterinary rabies vaccines
19. Use of a standardized extract from Echinacea angustifolia (Polinacea) for the prevention of respiratory tract infections
20. Evaluation of widely consumed botanicals as immunological adjuvants
21. Cytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallida
22. Phytochemical variation in echinacea from roots and flowerheads of wild and cultivated populations
23. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells
24. The majority of in vitro macrophage activation exhibited by extracts of some immune enhancing botanicals is due to bacterial lipoproteins and lipopolysaccharides
25. Total bacterial load within Echinacea purpurea, determined using a new PCR-based quantification method, is correlated with LPS levels and in vitro macrophage activity
26. Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial
27. Retention of alkamides in dried Echinacea purpurea
28. Retention of caffeic acid derivatives in dried Echinacea purpurea
29. Effect of drying temperature on alkylamide and cichoric acid concentrations of Echinacea purpurea
30. Effect of temperature on stability of marker constituents in Echinacea purpurea root formulations
31. Microbiology of pressure-treated foods
32. Effect of high pressure pasteurization on bacterial load and bioactivity of Echinacea purpurea
33. Efficacy and safety of Echinaforce® in respiratory tract infections
34. Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system
35. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways
36. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis
37. Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model
38. Transport of alkamides from Echinacea species through Caco-2 monolayers
39. Bioavailability of Echinacea constituents: Caco-2 monolayers and pharmacokinetics of the alkylamides and caffeic acid conjugates
40. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes
41. Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans
42. Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion
43. The bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MS
44. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo
45. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto
46. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea
47. Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients
48. Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjects
49. Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects
50. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions
51. Alkamides from Echinacea angustifolia Interact with P-glycoprotein of primary brain capillary endothelial cells isolated from porcine brain blood vessels
52. Echinacea sanguinea and Echinacea pallida extracts stimulate glucuronidation and basolateral transfer of Bauer alkamides 8 and 10 and ketone 24 and inhibit P-glycoprotein transporter in Caco-2 cells
53. The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots
54. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts
55. Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects
56. The role of alkamides as an active principle of echinacea
57. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety
58. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system
59. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)
60. The anxiolytic potential and psychotropic side effects of an echinacea preparation in laboratory animals and healthy volunteers
61. Effects of echinacea on electrocardiographic and blood pressure measurements
62. The pharmacology of cannabinoid receptors and their ligands: an overview
63. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats
64. Echinacea-induced macrophage activation
65. Modulation of macrophage immune responses by Echinacea
66. Variability in in vitro macrophage activation by commercially diverse bulk echinacea plant material is predominantly due to bacterial lipoproteins and lipopolysaccharides
67. LPS-induced cytokine production in human monocytes and macrophages
68. Phytochemical and immunomodulatory properties of an Echinacea laevigata (Asteraceae) tincture
69. Selective cytokine-inducing effects of low dose Echinacea
70. Dose-dependent in vivo effect of Rhodiola and Echinacea on the mitogen-induced lymphocyte proliferation in mice
71. Enhancement of innate and adaptive immune functions by multiple Echinacea species
72. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells
73. Antioxidant and immuno-enhancing effects of Echinacea purpurea
74. In vitro and in vivo immune stimulating effects of a new standardized Echinacea angustifolia root extract (Polinacea)
75. Effect of oral administration of freshly pressed juice of Echinacea purpurea on the number of various subpopulations of B- and T-lymphocytes in healthy volunteers: results of a double-blind, placebo-controlled cross-over study
76. Immunobiology of dendritic cells
77. Modulatory effects of Echinacea purpurea extracts on human dendritic cells: a cell- and gene-based study
78. Genomics and proteomics of immune modulatory effects of a butanol fraction of echinacea purpurea in human dendritic cells
79. Blocking effect of an immuno-suppressive agent, cynarin, on CD28 of T-cell receptor
80. Stimulatory effect of Echinacea purpurea extract on the trafficking activity of mouse dendritic cells: revealed by genomic and proteomic analyses
81. Anti-inflammatory effects of essential oil in Echinacea purpurea L
82. Increased production of antigen-specific immunoglobulins G and M following in vivo treatment with the medicinal plants Echinacea angustifolia and Hydrastis canadensis
83. Echinacea for preventing and treating the common cold
84. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis
85. Echinacea for preventing and treating the common cold
86. Assessing the quality of reports of randomized clinical trials: is blinding necessary?
87. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial
88. Echinacea purpurea for prevention of experimental rhinovirus colds
89. An evaluation of Echinacea angustifolia in experimental rhinovirus infections
90. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections
91. Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial
92. Efficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trial
93. Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study
94. Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trial
95. The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study
96. Limited agreement exists between rationale and practice in athletes' supplement use for maintenance of health: a retrospective study
97. Nutritional strategies to minimise exercise-induced immunosuppression in athletes
98. Exercise, nutrition and immune function
99. Open, multicenter study to evaluate the tolerability and efficacy of Echinaforce Forte tablets in athletes
100. Echinacea purpurea and mucosal immunity
101. Immunological and haematinic consequences of feeding a standardised Echinacea (Echinacea angustifolia) extract to healthy horses
102. Running economy and maximal oxygen consumption after 4 weeks of oral Echinacea supplementation
103. The effect of 4 wk of oral echinacea supplementation on serum erythropoietin and indices of erythropoietic status
104. The influence of active components of Eleutherococcus senticosus on cellular defence and physical fitness in man
105. Effect on prolactin secretion of Echinacea purpurea, hypericum perforatum and Eleutherococcus senticosus
106. Several culinary and medicinal herbs are important sources of dietary antioxidants
107. The efficacy of Echinacea in a 3-D tissue model of human airway epithelium
108. Echinacea stimulates macrophage function in the lung and spleen of normal rats
109. Echinacea purpurea aerial extract alters course of influenza infection in mice
110. Effect of oral application of an immunomodulating plant extract on Influenza virus type A infection in mice
111. Effects of ginseng and echinacea on cytokine mRNA expression in rats
112. A comparison of the immunostimulatory effects of the medicinal herbs Echinacea, Ashwagandha and Brahmi
113. Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children
114. Adverse effects of herbal medicines: an overview of systematic reviews
115. The safety of herbal medicinal products derived from Echinacea species: a systematic review
116. Pharmaceutical and herbal products that may contribute to dry eyes
117. Don't take echinacea if you're allergic to ragweed
118. Echinacea-associated anaphylaxis
119. Adverse reactions associated with echinacea: the Australian experience

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!